Correlation Between Partners Group and BB Biotech

Can any of the company-specific risk be diversified away by investing in both Partners Group and BB Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Partners Group and BB Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Partners Group Holding and BB Biotech AG, you can compare the effects of market volatilities on Partners Group and BB Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Partners Group with a short position of BB Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Partners Group and BB Biotech.

Diversification Opportunities for Partners Group and BB Biotech

0.13

Correlation Coefficient

Partners Group  BB Biotech

Average diversification

The 3 months correlation between Partners and BION is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Partners Group Holding and BB Biotech AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BB Biotech AG and Partners Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Partners Group Holding are associated (or correlated) with BB Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BB Biotech AG has no effect on the direction of Partners Group i.e., Partners Group and BB Biotech go up and down completely randomly.

Pair Corralation between Partners Group and BB Biotech

Assuming the 90 days trading horizon Partners Group is expected to generate 1.58 times less return on investment than BB Biotech. In addition to that, Partners Group is 1.06 times more volatile than BB Biotech AG. It trades about 0.11 of its total potential returns per unit of risk. BB Biotech AG is currently generating about 0.19 per unit of volatility. If you would invest  2,725  in BB Biotech AG on April 22, 2025 and sell it today you would earn a total of  525.00  from holding BB Biotech AG or generate 19.27% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Partners Group Holding  vs.  BB Biotech AG

Partners Group Holding

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Partners Group Holding are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Partners Group may actually be approaching a critical reversion point that can send shares even higher in August 2025.

BB Biotech AG

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in BB Biotech AG are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, BB Biotech showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Partners Group and BB Biotech

The main advantage of trading using opposite Partners Group and BB Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Partners Group position performs unexpectedly, BB Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BB Biotech will offset losses from the drop in BB Biotech's long position.

The idea behind Partners Group Holding and BB Biotech AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.